SCHEMBL6920465

SCHEMBL6920465

Cc1ccc2c(c1)c1c(n2Cc2ccc(F)cc2)CCCC1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.64
HDAC6 Q9UBN7 4/20 0.64
PTGS1 P23219 1/20 0.60
PTGS2 P35354 1/20 0.60
CACNB4 O00305 1/20 0.47
CACNA1A O00555 1/20 0.47
CACNA1G O43497 1/20 0.47
CACNG3 O60359 1/20 0.47
CACNA1F O60840 1/20 0.47
CACNA1H O95180 1/20 0.47
CACNB3 P54284 1/20 0.47
CACNA2D1 P54289 1/20 0.47
CACNG7 P62955 1/20 0.47
CACNA1B Q00975 1/20 0.47
CACNA1D Q01668 1/20 0.47
CACNB1 Q02641 1/20 0.47
CACNG1 Q06432 1/20 0.47
CACNB2 Q08289 1/20 0.47
CACNA1S Q13698 1/20 0.47
CACNA1C Q13936 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6923513 0.90 HDAC1 (0.76) HDAC1HDAC6PTGS1PTGS2CA1
SCHEMBL6925062 0.89 PTGS1 (0.58) HDAC1HDAC6PTGS1PTGS2CACNB4
SCHEMBL6926059 0.87 PTGS1 (0.67) HDAC1HDAC6PTGS1PTGS2CA1
SCHEMBL10155029 0.84 BCHE (0.61) HDAC1HDAC6CACNB4CACNA1ACACNA1G
SCHEMBL6921299 0.83 HDAC1 (0.69) HDAC1HDAC6PTGS1PTGS2CA1
SCHEMBL14894319 0.81 HDAC1 (0.79) HDAC1HDAC6PTGS1PTGS2ALDH1A1
SCHEMBL14894213 0.79 HDAC1 (0.76) HDAC1HDAC6PTGS1PTGS2
SCHEMBL14893889 0.78 HDAC1 (1.00) HDAC1HDAC6
SCHEMBL6925136 0.78 FABP4 (0.52) HDAC1HDAC6PTGS1PTGS2CA1
SCHEMBL7549327 0.77 PTGS1 (0.56) HDAC1HDAC6PTGS1PTGS2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed